Clinical Trial Update: Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the efficacy and safety of VQW-765 for on-demand treatment of Social Anxiety Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• VQW-765

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Social Anxiety Disorder (SAD) | Phase 3 | Status: RECRUITING